fluprednisolone has been researched along with Central Retinal Edema, Cystoid in 10 studies
Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.
Excerpt | Relevance | Reference |
---|---|---|
"To describe clinical outcomes associated with the use of topical difluprednate in treating uveitic cystoid macular edema." | 7.88 | Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. ( Acharya, NR; Browne, EN; Chhetri, P; Niemeyer, KM; Schallhorn, JM, 2018) |
"Twenty-seven patients (35 eyes) undergoing treatment with difluprednate 4 times daily for 3 weeks for noninfectious uveitic cystoid macular edema were reviewed for visual acuity, intraocular pressure, optical coherence tomography, and fluorescein angiography results." | 7.85 | RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE. ( Bena, J; Feiler, DL; Lowder, CY; Pichi, F; Srivastava, SK, 2017) |
"To evaluate the efficacy and safety of treatment of diabetic macular edema (persistent type) with difluprednate ophthalmic emulsion 0." | 7.83 | Efficacy and safety of topical difluprednate in persistent diabetic macular edema. ( Kaur, S; Sachdev, N; Singh, S; Yangzes, S, 2016) |
"To describe the use of topical difluprednate for the treatment of uveitic macular edema." | 7.83 | Topical difluprednate monotherapy for uveitic macular edema. ( Forooghian, F; Symes, RJ, 2016) |
"To evaluate the clinical effect of topical difluprednate in pediatric patients for treatment of noninfectious uveitis." | 7.78 | Efficacy and potential complications of difluprednate use for pediatric uveitis. ( Herlihy, E; Ongchin, S; Slabaugh, MA; van Gelder, RN, 2012) |
"To evaluate the efficacy of treatment of refractory diabetic macular edema (DME) after vitrectomy with difluprednate ophthalmic emulsion 0." | 7.76 | Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. ( Abe, S; Kirii, E; Nakano, S; Yamamoto, T; Yamashita, H, 2010) |
"To describe clinical outcomes associated with the use of topical difluprednate in treating uveitic cystoid macular edema." | 3.88 | Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. ( Acharya, NR; Browne, EN; Chhetri, P; Niemeyer, KM; Schallhorn, JM, 2018) |
"Twenty-seven patients (35 eyes) undergoing treatment with difluprednate 4 times daily for 3 weeks for noninfectious uveitic cystoid macular edema were reviewed for visual acuity, intraocular pressure, optical coherence tomography, and fluorescein angiography results." | 3.85 | RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE. ( Bena, J; Feiler, DL; Lowder, CY; Pichi, F; Srivastava, SK, 2017) |
"To evaluate the efficacy and safety of treatment of diabetic macular edema (persistent type) with difluprednate ophthalmic emulsion 0." | 3.83 | Efficacy and safety of topical difluprednate in persistent diabetic macular edema. ( Kaur, S; Sachdev, N; Singh, S; Yangzes, S, 2016) |
"To describe the use of topical difluprednate for the treatment of uveitic macular edema." | 3.83 | Topical difluprednate monotherapy for uveitic macular edema. ( Forooghian, F; Symes, RJ, 2016) |
"To evaluate the clinical effect of topical difluprednate in pediatric patients for treatment of noninfectious uveitis." | 3.78 | Efficacy and potential complications of difluprednate use for pediatric uveitis. ( Herlihy, E; Ongchin, S; Slabaugh, MA; van Gelder, RN, 2012) |
"To evaluate the efficacy of treatment of refractory diabetic macular edema (DME) after vitrectomy with difluprednate ophthalmic emulsion 0." | 3.76 | Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. ( Abe, S; Kirii, E; Nakano, S; Yamamoto, T; Yamashita, H, 2010) |
"Causes of panuveitis were considered and excluded based on a detailed history, physical examination, and laboratory investigations." | 1.33 | Conjunctival lymphoid hyperplasia presenting with bilateral panuveitis. ( Ioannidis, AS; Mulholland, B; Rai, P, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Moshirfar, M | 1 |
Somani, AN | 1 |
Motlagh, MN | 1 |
Ronquillo, YC | 1 |
Schallhorn, JM | 1 |
Niemeyer, KM | 1 |
Browne, EN | 1 |
Chhetri, P | 1 |
Acharya, NR | 1 |
Sathiamoorthi, S | 1 |
Ruddy, KJ | 1 |
Bakri, SJ | 1 |
Kaur, S | 1 |
Yangzes, S | 1 |
Singh, S | 1 |
Sachdev, N | 1 |
Symes, RJ | 1 |
Forooghian, F | 1 |
Feiler, DL | 1 |
Srivastava, SK | 1 |
Pichi, F | 1 |
Bena, J | 1 |
Lowder, CY | 1 |
Nakano, S | 1 |
Yamamoto, T | 2 |
Kirii, E | 2 |
Abe, S | 2 |
Yamashita, H | 2 |
Nakano Goto, S | 1 |
Slabaugh, MA | 1 |
Herlihy, E | 1 |
Ongchin, S | 1 |
van Gelder, RN | 1 |
Ioannidis, AS | 1 |
Rai, P | 1 |
Mulholland, B | 1 |
1 review available for fluprednisolone and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Management of cataract in the setting of uveitis: a review of the current literature.
Topics: Administration, Ophthalmic; Cataract; Cataract Extraction; Dexamethasone; Drug Implants; Flupredniso | 2020 |
9 other studies available for fluprednisolone and Central Retinal Edema, Cystoid
Article | Year |
---|---|
Difluprednate for the Treatment of Uveitic Cystoid Macular Edema.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Fluprednisolone; Follow-Up Studies; Humans; M | 2018 |
Association of Uveitis and Macular Edema With Anastrozole Therapy.
Topics: Aged; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorescein A | 2018 |
Efficacy and safety of topical difluprednate in persistent diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Female; Fluprednisolone; Follow-Up Studies; Glucocorticoids; Humans; Int | 2016 |
Topical difluprednate monotherapy for uveitic macular edema.
Topics: Administration, Topical; Adult; Female; Fluprednisolone; Glucocorticoids; Humans; Macular Edema; Mal | 2016 |
RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE.
Topics: Administration, Topical; Adult; Aged; Female; Fluorescein Angiography; Fluprednisolone; Glucocortico | 2017 |
Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema.
Topics: Diabetic Retinopathy; Emulsions; Female; Fluprednisolone; Glucocorticoids; Humans; Injections; Macul | 2010 |
Treatment of diffuse diabetic macular oedema using steroid eye drops.
Topics: Aged; Blood Glucose; Case-Control Studies; Diabetic Retinopathy; Emulsions; Female; Fluprednisolone; | 2012 |
Efficacy and potential complications of difluprednate use for pediatric uveitis.
Topics: Administration, Topical; Adolescent; Aqueous Humor; Cataract; Child; Female; Fluprednisolone; Glucoc | 2012 |
Conjunctival lymphoid hyperplasia presenting with bilateral panuveitis.
Topics: B-Lymphocytes; Conjunctival Diseases; Drug Combinations; Female; Fluprednisolone; Glucocorticoids; H | 2005 |